| 000 | a | ||
|---|---|---|---|
| 999 |
_c11016 _d11016 |
||
| 003 | OSt | ||
| 005 | 20200122104851.0 | ||
| 008 | 200122b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_911858 _aMukhopadhyay, Songhita |
||
| 245 |
_aFrom patient-centricity to personalization _b:A paradigm shift |
||
| 250 | _aVol.51(7), July | ||
| 260 |
_aMumbai _bIndian Pharmacutical Association _c2019 |
||
| 300 | _a12-17p. | ||
| 520 | _aNew Drug development has become a hub for pharma giants to explore various ways in which new chemical entities (NCE) can be developed which turns out to be most effective and safe for public... | ||
| 650 | 0 |
_94639 _aPHARMACEUTICS |
|
| 700 |
_911859 _aLewis, Shaila Angela |
||
| 773 | 0 |
_x0031-6849 _tPharma times _dNew Delhi Indian Pharmaceutical Association |
|
| 942 |
_2ddc _cAR |
||